Second major healthcare employer signs with DarioHealth, accelerating growth in 2025 and reinforcing its leadership in AI-powered, clinically validated digital health solutions for chronic condition management NEW YORK , April 8, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a new employer partners...
NEW YORK--(BUSINESS WIRE)--Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO)* emerges as a potential hidden gem in digital health as competitor Hinge Health prepares to go public at a multi-billion-dollar valuation, highlighting a dramatic valuation gap that savvy investors are beginning to notice. With Hinge Health filing for a potential April IPO at a valuation that according to re...
In the news release, DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base, issued 06-Feb-2025 by DarioHealth Corp. over PR Newswire, we are advised by the company to make multiple changes to the press release. The complete, corrected release follows: DarioHealth Announces New Agreement with a Large Regional Health Plan DarioHealth expands its payer netwo...
DarioHealth Corp. (NASDAQ:DRIO ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Conference Call Participants Charles Rhyee - TD Cowen Ashok Kumar - ThinkEquity David Grossman - Stifel Operator Good morning, ladies and gentlemen, and welcome t...
NEW YORK--(BUSINESS WIRE)---- $DRIO #Biotech--Market News Alerts Updates: Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO) reported fourth quarter revenue of $7.6 million, beating analyst consensus of $7.39 million. B2B2C recurring revenue surged 398% year-over-year to $5.6 million in Q4, driven by rapid employer and health plan adoption of the company's comprehensive chronic care p...
Full-year 2024 revenue increased by 32.9% to $27.0 million from $20.4 million revenue in 2023. Revenue growth driven by B2B2C channel including employers and health plans resulting in recurring revenues which increased by 300% year over year as core business continues to gain traction.
The strategic arrangement fuels Dario's B2B2C sales growth, expanding access to over 15,000 providers nationwide NEW YORK , March 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a strategic collaboration with Rula Health, a leading provider of high-quality behavioral health services, to expand acc...
Healthcare system collaborates with Dario to offer AI-powered chronic care management solutions as a benefit for their employee base of healthcare workers, expected to contribute to the current total of 15 new client signings in 2025, representing a significant head start in its 2025 net new client goal. NEW YORK , March 5, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.